Certara’s NLME Engine: Setting the Standard for Run Speed and Stability Fact Sheet Certara’s NLME Engine: Setting the Standard for Run Speed and Stability Why pharmacometricians are turning to the NLME engine from Certara PhoenixCertaraMay 28, 2026
Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned On-Demand Webinar Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned Learn how Phoenix NLME and RsNLME support advanced PK/PD workflows and complex pharmacometric modeling through…CertaraMay 20, 2026
Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace On-Demand Webinar Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve.Danielle PillsburyMay 8, 2026
What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD Blog What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD JTVCdGVhbV9qdW1wX2xpc3QlNUQ= May 8, 2026 At Certainty 2026, the Phoenix User Group Meeting brought together scientists,…CertaraMay 8, 2026
Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint On-Demand Webinar Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint Explore how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity,…CertaraMay 6, 2026
GxP Compliance in the Cloud: What IT Teams Need to Rethink Blog GxP Compliance in the Cloud: What IT Teams Need to Rethink Learn how GxP validation works in modern SaaS and cloud environments, with best practices for…CertaraMay 4, 2026
Allometric Approach in pharmacokinetics when and how to use it Webinar Allometric Approach in pharmacokinetics when and how to use it Danielle PillsburyApril 28, 2026
When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy Webinar When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy CertaraApril 10, 2026
PK Parameters Explained: From Cmax to Clearance (and Why It Matters for Development Decisions) Blog PK Parameters Explained: From Cmax to Clearance (and Why It Matters for Development Decisions) Learn how key PK parameters such as Cmax, AUC, clearance, half life, and volume of…CertaraApril 9, 2026
Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations On-Demand Webinar Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations Watch this on-demand webinar to learn how the final ICH M15 guidance is shaping Model-Informed…CertaraApril 2, 2026